4 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Low Back Pain: new trials by email Literature Review of Low Back Pain trials Research Report on Low Back Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Abaloparatide on Lumbar Disc Degeneration Abaloparatide, Placebo - Degeneration Disc Intervertebral | Phase 2 | Withdrawn | Johns Hopkins University | 2021-03-01 | 2021-04-12 | |
| Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain 3-glycosyl-3-Odemethylthiocolchicine derivative - Low Back Pain | Phase 2 | Withdrawn | Indena S.p.A | 2016-04-01 | 2025-07-22 | |
| Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV) Autologous bone marrow mesenchymal stem cells - Degenerative Disc Disease | Phase 1 / Phase 2 | Withdrawn | Red de Terapia Celular | 2011-06-01 | 2015-05-12 | |
| Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression System for Treatment of Low Back Pain DRX9000™ - Low Back Pain | Phase 2 | Withdrawn | NEMA Research, Inc. | 2009-02-01 | 2015-10-12 |
Intervertebral Disc Degeneration (2) · Muscle Hypotonia (1)
Back Pain (4) · Neurologic Manifestations (4) · Pain (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Bone Diseases (2) · Musculoskeletal Diseases (2) · Spinal Diseases (2) · Nervous System Diseases (1) · Neuromuscular Manifestations (1)
Genes, mos (1) · Parathyroid Hormone-Related Protein (1) · abaloparatide (1)
Indena S.p.A (1) · Johns Hopkins University (1) · NEMA Research, Inc. (1) · Red de Terapia Celular (1)
United States (2) · Italy (1)
Charlotte Richmond, PhD (1) · Gianfranco Ferraccioli, MD (1) · Janet Crane, M.D. (1) · Joseph V Pergolizzi, MD (1)